These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 27267001

  • 21. Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
    Mohd Siddique MU, Thakur A, Shilkar D, Yasmin S, Halakova D, Kovacikova L, Prnova MS, Stefek M, Acevedo O, Dasararaju G, Devadasan V, Mondal SK, Jayaprakash V.
    Eur J Med Chem; 2021 Nov 05; 223():113630. PubMed ID: 34175538
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S, Parveen S, Qin X, Hao X, Zhang S, Chen X, Zhu C, Ma B.
    Bioorg Med Chem Lett; 2014 May 01; 24(9):2086-9. PubMed ID: 24726808
    [Abstract] [Full Text] [Related]

  • 24. Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
    La Motta C, Sartini S, Mugnaini L, Simorini F, Taliani S, Salerno S, Marini AM, Da Settimo F, Lavecchia A, Novellino E, Cantore M, Failli P, Ciuffi M.
    J Med Chem; 2007 Oct 04; 50(20):4917-27. PubMed ID: 17845019
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Design and synthesis of N-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides as aldose reductase inhibitors.
    Alexiou P, Nicolaou I, Stefek M, Kristl A, Demopoulos VJ.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3926-32. PubMed ID: 18267362
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition.
    Javid N, Munir R, Chaudhry F, Imran A, Zaib S, Muzaffar A, Iqbal J.
    Bioorg Chem; 2020 Jun 01; 99():103852. PubMed ID: 32325339
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
    Costantino L, Rastelli G, Gamberini MC, Vinson JA, Bose P, Iannone A, Staffieri M, Antolini L, Del Corso A, Mura U, Albasini A.
    J Med Chem; 1999 Jun 03; 42(11):1881-93. PubMed ID: 10354396
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.
    Maccari R, Vitale RM, Ottanà R, Rocchiccioli M, Marrazzo A, Cardile V, Graziano AC, Amodeo P, Mura U, Del Corso A.
    Eur J Med Chem; 2014 Jun 23; 81():1-14. PubMed ID: 24819954
    [Abstract] [Full Text] [Related]

  • 40. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K, Pratsinis H, Kletsas D, Quattrini L, Coviello V, Motta C, El-Rashedy AA, Soliman ME.
    Future Med Chem; 2017 Dec 23; 9(18):2147-2166. PubMed ID: 29098865
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.